Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR versus codeine + paracetamol for chronic low back pain or osteoarthritis pain
2008-002426-10Phase 3Completed
- Sponsor
- Napp Pharmaceuticals
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) and osteoarthritis (OA) comparing Oxycodone + naloxone prolonged release with Codeine + paracetamol (2 arms). Primary endpoint: Average daily pain score. Started Aug 2008; status: completed.
02
Drugs
oxycodone + naloxoneParacetamol + codeine
03
Conditions
chronic low back pain (CLBP)osteoarthritis (OA)
Beyond the preview
Go deeper on 2008-002426-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002426-10.